Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03840824 · ClinicalTrials.gov registry record
Blood Spot Self-administered Test and Assay
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 80
- Enrollment target
NCT03840824: Completed study, sponsored by University of Pennsylvania.
NCT03840824 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03840824 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
The current study will compare hormone levels of AMH, FSH and inhibin B in blood specimens collected by venipuncture and fingerstick in a sample of pre-menopausal women ages 18-45 years with normal menstrual cycles.
Primary Outcome
Serum AMH ELISA assay results will be compared to capillary blood sample AMH collected on filter paper and dried. Recovery of spiked ligands, sensitivity and specificity of the assays will be also assessed.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2010-10 |
| Est. Completion | 2016-08 |
What the finished NCT03840824 record still lists
NCT03840824 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03840824 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03840824 about?
NCT03840824 is a clinical study titled "Blood Spot Self-administered Test and Assay". The current study will compare hormone levels of AMH, FSH and inhibin B in blood specimens collected by venipuncture and fingerstick in a sample of pre-menopausal women ages 18-45 years with normal menstrual cycles.
What is the current status of trial NCT03840824?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2010-10. Estimated completion is 2016-08.
Who is sponsoring clinical trial NCT03840824?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia